Mycobiology

The Korean Society of Mycology (한국균학회)
권호 표지
DOI QR코드

DOI QR Code

Isolation Frequency Characteristics of Candida Species from Clinical Specimens

  • Kim, Ga-Yeon (Department of Dental Hygiene, College of Health Sciences, Dankook University) ;
  • Jeon, Jae-Sik (Department of Laboratory Medicine, College of Medicine, Dankook University) ;
  • Kim, Jae Kyung (Department of Biomedical Laboratory Science, College of Health Sciences, Dankook University)
  • Received : 2016.05.16
  • Accepted : 2016.06.22
  • Published : 2016.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Candida spp. is an invasive infectious fungus, a major risk factor that can increase morbidity and mortality in hospitalized patients. In this study, 2,508 Candida spp. were isolated from various clinical specimens collected from university hospitals from July 2011 to October 2014. They were identified in order to determine isolation frequencies and characteristics by specimen, gender, age group, year, season, and month. The strain-specific isolation rate of Candida spp. is in the order of Candida albicans (1,218 strains, 48.56%), Candida glabrata (416 strains, 16.59%), Candida utilis (305 strains, 12.16%), Candida tropicalis (304 strains, 12.12%), and Candida parapsilosis (116 strains, 4.63%) and these five species accounted for more than 94% of the total strains. Of the specimens, Candida spp. were most frequently isolated from urine-catheter, followed by urinevoided, blood, sputum, other, open pus, vaginal discharge, Tip, ear discharge, bronchial aspiration and bile, in that order. Looking at the age distribution, the detection rate of patients in their 60s and older was significantly higher at 75.8% (1,900/2,508). The detection rate of patients in their 20s and younger was shown to be very low at 2.55% (64/2,508). By year, the detection rate of non-albicans Candida spp. showed a tendency to gradually increase each year compared with C. albicans. As isolation of Candida spp. from clinical samples at the specie level can vary depending on characteristics of the patient, sample, season, etc., continual studies are required.

Keywords

References

  1. Kim YK, Ki MR, Yim JS, Kim KH, Song YJ, Choi HY, Seo CW, Park JS. Epidemiological characteristic study of domestic and imported mycoses. Cheongju: Korea Centers for Disease Control and Prevention (KCDC); 2012.
  2. McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001;33:641-7. https://doi.org/10.1086/322606
  3. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995;20:1526-30. https://doi.org/10.1093/clinids/20.6.1526
  4. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999;29:239-44. https://doi.org/10.1086/520192
  5. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of populationbased laboratory active surveillance. Clin Infect Dis 1998;27:1138-47. https://doi.org/10.1093/clinids/27.5.1138
  6. Knoke M, Schulz K, Bernhardt H. Dynamics of Candida isolations from humans from 1992-1995 in Greifswald, Germany. Mycoses 1997;40:105-10. https://doi.org/10.1111/j.1439-0507.1997.tb00197.x
  7. Shin JH, Lim WH, Shin DH, Suh SP, Ryang DW. Candida species isolated from clinical specimens and medical personnel. Korean J Infect Dis 1999;31:481-6.
  8. Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, Baughman WS, Reingold AL, Rothrock GA, Pfaller MA, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999;29:1164-70. https://doi.org/10.1086/313450
  9. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642-5. https://doi.org/10.1001/archinte.1988.00380120094019
  10. National Committee for Clinical Laboratory Standards. Reference method for broth dilution: antifungal susceptibility testing of yeasts. Approved standard M27-A2. Wayne (PA): Clinical and Laboratory Standards Institute; 2008.
  11. Graf B, Adam T, Zill E, Gobel UB. Evaluation of the VITEK 2 system for rapid identification of yeasts and yeast-like organisms. J Clin Microbiol 2000;38:1782-5.
  12. Chen YC, Eisner JD, Kattar MM, Rassoulian-Barrett SL, Lafe K, Bui U, Limaye AP, Cookson BT. Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J Clin Microbiol 2001;39:4042-51. https://doi.org/10.1128/JCM.39.11.4042-4051.2001
  13. St-Germain G, Laverdière M, Pelletier R, Bourgault AM, Libman M, Lemieux C, Noel G. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol 2001;39:949-53. https://doi.org/10.1128/JCM.39.3.949-953.2001
  14. Pfaller MA, Messer SA, Hollis RJ, Jones RN, Doern GV, Brandt ME, Hajjeh RA. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis 1999;33:217-22. https://doi.org/10.1016/S0732-8893(98)00160-6
  15. Arias A, Arevalo MP, Andreu A, Rodriguez C, Sierra A. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents. Mycoses 1994;37:285-9.
  16. Nguyen MH, Peacock JE Jr, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, Wagener MM, Rinaldi MG, Yu VL. The changing face of candidemia: emergence of not-Candida albicans species and antifungal resistance. Am J Med 1996;100:617-23. https://doi.org/10.1016/S0002-9343(95)00010-0
  17. Shin HS, Park YB, Shin DS. Isolation frequency of Candida species from clinical specimens. Kor J Mycol 2010;38:146-51. https://doi.org/10.4489/KJM.2010.38.2.146
  18. Shin JH, Kim HR, Lee JN. Distribution and antifungal susceptibility of Candida species isolated from clinical specimens during the past six years. Korean J Clin Microbiol 2004;7:164-70.
  19. Fernandes R, Viegas A, Cerqueira F. Candida species distribution in clinical samples. Revista da Faculdade de Ciencias da Saude. Porto: Edicoes Universidade Fernando Pessoa; 2009. p. 264-71.
  20. Kang BK, Lee HJ, Suh JT. The trends of the species and antimicrobial susceptibility of bacteria and fungi isolated from blood cultures (1986-1996). Korean J Clin Pathol 1998;18:57-64.
  21. Uh Y, Jang IH, Yoon KJ, Kim HY. Isolation trend and antifungal susceptibility of Candida species isolated from blood cultures. Korean J Infect Dis 2001;33:186-93.
  22. Moon HJ, Lee JB, Kim SJ, Lee SC, Won YH. Clinical and mycological studies on dermatomycosis (1991-2000). Korean J Med Mycol 2002;7:78-85.
  23. Kim JS, Won YH, Chun IK, Kim YP. Clinical and mycological studies on dermatomycosis. Korean J Dermatol 1992;30:68-75.
  24. Shin JH, Lim WH, Shin DH, Suh SP, Ryang DW. Antifungal susceptibilities to fulconazole and itraconazole for Candida species recovered from blood cultures over a 5-year period. Korean J Infect Dis 2000;32:179-85.
  25. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998;31:327-32. https://doi.org/10.1016/S0732-8893(97)00240-X